Side effects of novel drugs and managing patient expectations in CLL
Can biosimilars ensure access to drugs for everyone?
The role of transplant in the era of new treatments for lymphoma and CLL
The progress of CLL research: towards targeted therapy
The iwCLL 2017 meeting